Meeting
2022 ASCO Quality Care Symposium
The financial impact of reducing drug waste with biosimilar transition of trastuzumab in the Oncology Care Model for the U.S. Oncology Network.
Authors
Jennifer Fernandez
The U.S. Oncology Network, McKesson, The Woodlands, TX
Jennifer Fernandez, Puneeth Indurlal, Jody S. Garey, Neal Dave, Richard Cleveland, Jody Agena, Rajat Malhotra, Lalan S. Wilfong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Cost and Cost-Effectiveness of Care
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 11)
DOI
10.1200/JCO.2022.40.28_suppl.011
Abstract #
11
Poster Bd #
A9
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Quality Care Symposium
Quantifying episode-based costs of care under the oncology care model: Analysis of Medicare beneficiaries in the UAB cancer community network.
First Author: Courtney Williams
Poster
2013 ASCO Quality Care Symposium
Evaluating adherence to off-label policy at an academic outpatient cancer center and assessing reimbursement of high-cost drugs.
First Author: Gayle C. Blouin
Poster
2024 ASCO Annual Meeting
Medicare reimbursement trends of biological reference agents and their biosimilars.
First Author: John Albaugh
Poster
2023 ASCO Quality Care Symposium
Trend in breakdown of total cost of care for medical oncology over time: Learnings from the Oncology Care Model and implications for future oncology value-based care.
First Author: Leah Owens